RAPP
Rapport Therapeutics, Inc.
40.50$
-3.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +391.8% | +102.6% | +62.7% | |
| – | +382.5% | +105.3% | +60.9% | |
| – | +125.2% | -19.0% | -7.3% | |
| – | +373.3% | +107.0% | +60.7% | |
| – | +1,396.6% | -94.7% | +192.2% | |
| – | +429.3% | -0.4% | +117.3% | |
| – | – | +10.0% | +273.8% | |
| – | +72.6% | -21.9% | +114.4% | |
| – | -231.4% | – | +58.7% | |
| – | – | – | – | |
| – | -10.1% | +14.7% | +126.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.